TEMPORARY REMOVAL: The therapeutic effects of Longikaurin A, a natural ent-kauranoid, in esophageal squamous cell carcinoma depend on ROS accumulation and JNK/p38 MAPK activation (Retraction of Vol 280, Pg 1, 2017)
Che, Yun1,2; Wang, Jingnan1,2; Yuan, Zuyang1,2; Li, Yuan1,2; Lu, Zhiliang1,2; Zhang, Zhirong1,2; Zhang, Jinyao1,2; Wan, Jun3; Sun, Handong3; Chen, Zhaoli1,2; Pu, Jianxin3; He, Jie1,2
2017-10-05
发表期刊TOXICOLOGY LETTERS
ISSN0378-4274
卷号280页码:106-106
语种英语
引用统计
文献类型期刊论文
条目标识符http://ir.kib.ac.cn/handle/151853/60348
专题植物化学与西部植物资源持续利用国家重点实验室
作者单位1.Chinese Acad Med Sci, Canc Hosp, Natl Canc Ctr, Dept Thorac Surg, Beijing 100021, Peoples R China
2.Peking Union Med Coll, Beijing 100021, Peoples R China
3.Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming 650201, Yunnan, Peoples R China
推荐引用方式
GB/T 7714
Che, Yun,Wang, Jingnan,Yuan, Zuyang,et al. TEMPORARY REMOVAL: The therapeutic effects of Longikaurin A, a natural ent-kauranoid, in esophageal squamous cell carcinoma depend on ROS accumulation and JNK/p38 MAPK activation (Retraction of Vol 280, Pg 1, 2017)[J]. TOXICOLOGY LETTERS,2017,280:106-106.
APA Che, Yun.,Wang, Jingnan.,Yuan, Zuyang.,Li, Yuan.,Lu, Zhiliang.,...&He, Jie.(2017).TEMPORARY REMOVAL: The therapeutic effects of Longikaurin A, a natural ent-kauranoid, in esophageal squamous cell carcinoma depend on ROS accumulation and JNK/p38 MAPK activation (Retraction of Vol 280, Pg 1, 2017).TOXICOLOGY LETTERS,280,106-106.
MLA Che, Yun,et al."TEMPORARY REMOVAL: The therapeutic effects of Longikaurin A, a natural ent-kauranoid, in esophageal squamous cell carcinoma depend on ROS accumulation and JNK/p38 MAPK activation (Retraction of Vol 280, Pg 1, 2017)".TOXICOLOGY LETTERS 280(2017):106-106.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Che, Yun]的文章
[Wang, Jingnan]的文章
[Yuan, Zuyang]的文章
百度学术
百度学术中相似的文章
[Che, Yun]的文章
[Wang, Jingnan]的文章
[Yuan, Zuyang]的文章
必应学术
必应学术中相似的文章
[Che, Yun]的文章
[Wang, Jingnan]的文章
[Yuan, Zuyang]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。